CNBX Pharmaceuticals said it replaced Elkana Amitai CPA with Vilki & Co as its independent accounting firm, effective September 28, 2026. The company said the change was not caused by a disagreement with its former auditor. CNBX disclosed the appointment in a Form 8-K filed October 1, 2026.
Who is CNBX Pharmaceuticals’ new auditor?
CNBX engaged Vilki & Co on September 28, 2026, for the fiscal year ended August 31, 2026, and dismissed Elkana Amitai CPA effective that same day. The SEC filing index lists the October 1, 2026 Form 8-K under Item 4.01, “Changes in Registrant’s Certifying Accountant.” SEC filing index
Why did CNBX replace Elkana Amitai CPA?
CNBX stated that the auditor change did not result from a disagreement over accounting principles or practices, financial-statement disclosures, or the scope or procedures of the audit. The company also reported no disagreements or reportable events for the periods specified in its filing. SEC-filed materials
The appointment disclosure does not establish why CNBX chose Vilki & Co beyond the company’s stated explanation that the transition was not due to a disagreement. It also does not establish an audit opinion or assurance outcome from the incoming firm.
#1 Best Overall
What did the outgoing auditor say?
In a letter dated October 1, 2026, Elkana Amitai CPA agreed with the statements in CNBX’s filing concerning its firm, while declining to take a position on other statements by the company: “We agree with the statements concerning our firm contained therein. We have no basis to agree or disagree with other statements of the registrant contained therein.” SEC-filed letter from Elkana Amitai CPA
That response is limited: the former auditor did not endorse every statement made by CNBX.
Rank #2
- QUALITY INVOICES: Adams Order books provide a professional invoice or customer receipt; a great way to create and maintain a professional image for small businesses and service providers
- 50 TWO-PART CARBONLESS FORMS: Customers get the perforated white top copy; retain the canary and pink copies for your records
- WRAP-AROUND COVER: Fold the back cover between sets to keep invoices neat and legible
- ROOM FOR CUSTOMIZATION: A blank space at top leaves room for your company stamp; a big savings over custom-printed forms
- CONSECUTIVELY NUMBERED: Large 6-digit numbers in the upper right hand corner help you thumb through orders quickly
How this change fits CNBX’s auditor history
CNBX previously replaced Weinstein International CPA with Elkana Amitai CPA effective March 18, 2024. The 2024 filing reported no disagreements or reportable events for the periods it covered; it provides chronology, not an explanation for the 2026 transition. CNBX’s 2024 Form 8-K
CNBX’s fiscal 2025 Form 10-K describes the company as clinical-stage and developing cannabinoid-based cancer treatments, with RCC-33 identified as its leading colorectal cancer candidate. Elkana Amitai CPA’s audit reports for fiscal years 2024 and 2025 included going-concern explanatory paragraphs, as described in the 2026 filing materials. Those historical disclosures are separate from CNBX’s stated reason for the auditor change; the company said the transition was not due to disagreement. CNBX fiscal 2025 Form 10-K
Free tools Windows power users keep installed
One-click scans. No signup required.
Quick Recap
Rank #3
- Used Book in Good Condition
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
